Performance and clinical decision-making using the prognostic 40-gene expression profile (40-GEP) test in 1,018 patients with high-risk cutaneous squamous cell carcinoma (SCC)

Main Article Content

Jennifer J Siegel
Anesh Prasai
Aaron S Farberg
Matthew S Goldberg


high-risk, cutaneous squamous cell carcinoma, 40-gene expression profile, 40-GEP, performance, clinical decision-making, prognosis


1. Rogers, JAMA Derm 2015

2. Karia, JAAD 2013

3. Cañueto, JAAD 2019

4. Ruiz, JAMA Derm 2019

5. NCCN Guidelines V2.2022

6. Wysong, JAAD 2021

7. Ibrahim, Future Onc 2021

8. Hooper, Cancer Inv 2022

9. Teplitz, JDD 2019

Most read articles by the same author(s)